Chuan Liu1, Qing-Shui Wang, Ya-Jie Wang. 1. Department of Oncology, Changhai Hospital, The Second Military Medical University, Shanghai, China.
Abstract
BACKGROUND: The cell cycle checkpoint kinase 2 (CHEK2) gene I157T variant may be associated with an increased risk of colorectal cancer, but it is unclear whether the evidence is sufficient to recommend testing for the mutation in clinical practice. MATERIALS AND METHODS: We systematically searched PubMed, EMBASES, Elsevier and Springer for relevant articles before Apr 2012. Summary odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated using a fixed-effects or random-effects models with Review Manager 5.0 software. RESULTS: A total of seven studies including 4,029 cases and 13,844 controls based on the search criteria were included for analysis. A significant association of the CHEK2 I157T C variant with unselected CRC was found (OR=1.61, 95% CI=1.40-1.87, P<0.001). We also found a significant association with sporadic CRC (OR=1.48, 95% CI=1.23-1.77, P<0.001) and separately with familial CRC (OR=1.97, 95% CI=1.41-2.74, P<0.001). CONCLUSION: This meta-analysis demonstrates that the CHEK2 I157T variant may be another important CRC-predisposing gene, which increases CRC risk, especially in familial CRC.
BACKGROUND: The cell cycle checkpoint kinase 2 (CHEK2) gene I157T variant may be associated with an increased risk of colorectal cancer, but it is unclear whether the evidence is sufficient to recommend testing for the mutation in clinical practice. MATERIALS AND METHODS: We systematically searched PubMed, EMBASES, Elsevier and Springer for relevant articles before Apr 2012. Summary odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated using a fixed-effects or random-effects models with Review Manager 5.0 software. RESULTS: A total of seven studies including 4,029 cases and 13,844 controls based on the search criteria were included for analysis. A significant association of the CHEK2I157T C variant with unselected CRC was found (OR=1.61, 95% CI=1.40-1.87, P<0.001). We also found a significant association with sporadic CRC (OR=1.48, 95% CI=1.23-1.77, P<0.001) and separately with familial CRC (OR=1.97, 95% CI=1.41-2.74, P<0.001). CONCLUSION: This meta-analysis demonstrates that the CHEK2I157T variant may be another important CRC-predisposing gene, which increases CRC risk, especially in familial CRC.
Authors: Saud H AlDubayan; Louise C Pyle; Marija Gamulin; Tomislav Kulis; Nathanael D Moore; Amaro Taylor-Weiner; Anis A Hamid; Brendan Reardon; Bradley Wubbenhorst; Rama Godse; David J Vaughn; Linda A Jacobs; Stefanie Meien; Mislav Grgic; Zeljko Kastelan; Sarah C Markt; Scott M Damrauer; Daniel J Rader; Rachel L Kember; Jennifer T Loud; Peter A Kanetsky; Mark H Greene; Christopher J Sweeney; Christian Kubisch; Katherine L Nathanson; Eliezer M Van Allen; Douglas R Stewart; Davor Lessel Journal: JAMA Oncol Date: 2019-04-01 Impact factor: 33.006
Authors: Thomas U Ahearn; Haoyu Zhang; Montserrat García-Closas; Nilanjan Chatterjee; Kyriaki Michailidou; Roger L Milne; Manjeet K Bolla; Joe Dennis; Alison M Dunning; Michael Lush; Qin Wang; Irene L Andrulis; Hoda Anton-Culver; Volker Arndt; Kristan J Aronson; Paul L Auer; Annelie Augustinsson; Adinda Baten; Heiko Becher; Sabine Behrens; Javier Benitez; Marina Bermisheva; Carl Blomqvist; Stig E Bojesen; Bernardo Bonanni; Anne-Lise Børresen-Dale; Hiltrud Brauch; Hermann Brenner; Angela Brooks-Wilson; Thomas Brüning; Barbara Burwinkel; Saundra S Buys; Federico Canzian; Jose E Castelao; Jenny Chang-Claude; Stephen J Chanock; Georgia Chenevix-Trench; Christine L Clarke; J Margriet Collée; Angela Cox; Simon S Cross; Kamila Czene; Mary B Daly; Peter Devilee; Thilo Dörk; Miriam Dwek; Diana M Eccles; D Gareth Evans; Peter A Fasching; Jonine Figueroa; Giuseppe Floris; Manuela Gago-Dominguez; Susan M Gapstur; José A García-Sáenz; Mia M Gaudet; Graham G Giles; Mark S Goldberg; Anna González-Neira; Grethe I Grenaker Alnæs; Mervi Grip; Pascal Guénel; Christopher A Haiman; Per Hall; Ute Hamann; Elaine F Harkness; Bernadette A M Heemskerk-Gerritsen; Bernd Holleczek; Antoinette Hollestelle; Maartje J Hooning; Robert N Hoover; John L Hopper; Anthony Howell; Milena Jakimovska; Anna Jakubowska; Esther M John; Michael E Jones; Audrey Jung; Rudolf Kaaks; Saila Kauppila; Renske Keeman; Elza Khusnutdinova; Cari M Kitahara; Yon-Dschun Ko; Stella Koutros; Vessela N Kristensen; Ute Krüger; Katerina Kubelka-Sabit; Allison W Kurian; Kyriacos Kyriacou; Diether Lambrechts; Derrick G Lee; Annika Lindblom; Martha Linet; Jolanta Lissowska; Ana Llaneza; Wing-Yee Lo; Robert J MacInnis; Arto Mannermaa; Mehdi Manoochehri; Sara Margolin; Maria Elena Martinez; Catriona McLean; Alfons Meindl; Usha Menon; Heli Nevanlinna; William G Newman; Jesse Nodora; Kenneth Offit; Håkan Olsson; Nick Orr; Tjoung-Won Park-Simon; Alpa V Patel; Julian Peto; Guillermo Pita; Dijana Plaseska-Karanfilska; Ross Prentice; Kevin Punie; Katri Pylkäs; Paolo Radice; Gad Rennert; Atocha Romero; Thomas Rüdiger; Emmanouil Saloustros; Sarah Sampson; Dale P Sandler; Elinor J Sawyer; Rita K Schmutzler; Minouk J Schoemaker; Ben Schöttker; Mark E Sherman; Xiao-Ou Shu; Snezhana Smichkoska; Melissa C Southey; John J Spinelli; Anthony J Swerdlow; Rulla M Tamimi; William J Tapper; Jack A Taylor; Lauren R Teras; Mary Beth Terry; Diana Torres; Melissa A Troester; Celine M Vachon; Carolien H M van Deurzen; Elke M van Veen; Philippe Wagner; Clarice R Weinberg; Camilla Wendt; Jelle Wesseling; Robert Winqvist; Alicja Wolk; Xiaohong R Yang; Wei Zheng; Fergus J Couch; Jacques Simard; Peter Kraft; Douglas F Easton; Paul D P Pharoah; Marjanka K Schmidt Journal: Breast Cancer Res Date: 2022-01-04 Impact factor: 8.408
Authors: Felipe Antonio de Oliveira Garcia; Edilene Santos de Andrade; Henrique de Campos Reis Galvão; Cristina da Silva Sábato; Natália Campacci; Andre Escremin de Paula; Adriane Feijó Evangelista; Iara Viana Vidigal Santana; Matias Eliseo Melendez; Rui Manuel Reis; Edenir Inez Palmero Journal: Sci Rep Date: 2022-02-18 Impact factor: 4.379